1
Observational Study of Camrelizumab Combined With Apatinib and Hyperfractionated Radiotherapy for Renal Cell Carcinoma
Condition(s):Renal Cell CarcinomaLast Updated:October 30, 2020Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Renal Cell CarcinomaLast Updated:October 30, 2020Not yet recruiting
Condition(s):Immunotherapy; SBRT; Bulky TumorLast Updated:October 14, 2020Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.